TTrialPathMatch Me to Trials
← Back to trials
RecruitingRetinoblastomaRetinoblastoma BilateralRetinoblastoma Unilateral

Retinoblastoma Patient Clinical Database and Tissue Repository

Eligible age

0–18 yrs

Accepts

All genders

Locations

8 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed. Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.

Sponsor: Children's Hospital Los Angeles

You may qualify if…

  • All patients, age 0 days to 18 years, with a diagnosis unilateral or bilateral retinoblastoma (RB) seen at CHLA (Children's Hospital Los Angeles).

You may not qualify if…

  • Patients referred for second opinions only and not treated at CHLA for any reason.

Where it's recruiting

Arizona

Phoenix

California

Los Angeles

Georgia

Atlanta

Illinois

Chicago

Oregon

Portland

Pennsylvania

Philadelphia

Tennessee

Memphis

Washington

Seattle

Source: ClinicalTrials.gov · NCT04959097 · last updated 2026-04-22

Retinoblastoma Patient Clinical Database and Tissue Repository · TrialPath